{
  "id": 9582742,
  "title": "10-Year Data Back Early Start to Biologics in Arthritic Diseases",
  "url": "https://urgent.news/2026/09/24/10-year-data-back-early-start-to-biologics-in-arthritic-diseases",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-24T15:30:23.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/rheumatology/arthritis/123129"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- Many patients treated with golimumab (Simponi) for newly diagnosed peripheral spondyloarthritis (pSpA) in a small trial achieved sustained drug-free remission after 10 years of follow-up, researchers found. With 49 of the trial...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}